Arkolith/Insider Trading/SONN/Form 4

Kenney Richard T

Chief Medical OfficerSonnet BioTherapeutics Holdings, Inc. (SONN) · full profile →Form 4 · filed Dec 4, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 2, 2025Disposed to issuer(D)70K——0
Dec 2, 2025Option exercise(M)164K——164K
Dec 2, 2025Disposed to issuer(D)164K——0
Dec 2, 2025Tax withholding(F)17K——70K
Dec 2, 2025Disposed to issuer(D)9K——0
Dec 2, 2025Option exercise(M)87K——87K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 2, 2025Option exercise(M)87K——0
Dec 2, 2025Option exercise(M)200——0
Dec 2, 2025Disposed to issuer(D)320K——0

Transaction Codes

D
Disposition to the issuer
M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-25-026217) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML